An anti - obesity drug: Caralluma fimbriata wall.

Authors

  • Sharma Ravindar national institute of ayurveda jaipur
  • Agrawal Rachna
  • Malviya Reeta
  • Rama Murthy A

DOI:

https://doi.org/10.47552/ijam.v4i2.286

Keywords:

Caralluma fimbriata Wall., Obesity, Nutraceutical drug, Suppress appetite

Abstract

Obesity is a major global health problem and a risk factor for several chronic disorders such as diabetes, hyperlipidemia, hypertension and cardiovascular disease.

There are various pharmacological treatments available for obesity but their use is limited by various adverse effects.

Caralluma fimbriata Wall. is a plant which has been used to suppress the hunger and caloric intake and also help increase the endurance people.

This review focus on patents related to caralluma fimbriata, as well as other nutraceutical.

 

Author Biographies

Sharma Ravindar, national institute of ayurveda jaipur

md scholer dravyaguna department

Agrawal Rachna

P.G. Scholar, Dept. of P.G. Studies in Swasthvrat, National Institute of Ayurveda, Jaipur, Rajasthan

Malviya Reeta

P.G. Scholar, Dept. of P.G. Studies in Dravya Guna. National Institute of Ayurveda, Jaipur, Rajasthan.

Rama Murthy A

Asst.Prof. Dept. of P.G. Studies in Dravya Guna. National Institute of Ayurveda, Jaipur, Rajasthan.

Downloads

Published

2013-06-26

How to Cite

Ravindar, S., Rachna, A., Reeta, M., & A, R. M. (2013). An anti - obesity drug: Caralluma fimbriata wall. International Journal of Ayurvedic Medicine, 4(2). https://doi.org/10.47552/ijam.v4i2.286

Issue

Vol. 4 No. 2 (2013): April - June 2013

Section

Review Articles

License

The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.

This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.

The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.

https://creativecommons.org/licenses/by-nc-sa/4.0/